Smart Patients Get Smart Care™
The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients
At the annual meeting of the European Hematology Association (EHA) 2021, our own Dr. Brian Koffman spoke with Dr. Jennifer Woyach, a professor of medicine and hematologist at the James Cancer Center of the Ohio State University, about 2 ongoing clinical trials that are currently recruiting patients with CLL.
Join CLL Society for this important Ed Forum to learn the basics about testing across the span of your CLL journey. At the time of diagnosis, find out which tests should be performed, which might be avoided, and why. Before starting your first treatment, and prior to every subsequent treatment, know which tests you absolutely must have, which we strongly advise through CLL Society’s Test Before Treat™ campaign. Two patients will share their stories about the importance of getting the right tests completed prior to choosing treatment. Finally, learn how CLL is monitored over time, and how the evolving role of MRD (measurable residual disease) testing may help determine when to stop therapy in CLL.
While this is not a CLL specific topic, it is research on a subject that is critical to our mission at CLL Society to be an inclusive organization and encourage diversity in all cancer clinical trials.
The use of CT scans is an effective diagnostic method to assess internal organs and disease status, as well as the effect of treatment in cancer patients. CT scans, with or
CLL Clinical Trials CLL is not a solved problem, but we do have excellent treatments. It was only through clinical trials that the safety and efficacy of existing therapies was proven, and the
ASH, short for the American Society of Hematology Annual Meeting and Exposition, is the showcase for the latest and best results from the research, mostly clinical trial data, in hematology. But
Clinical trials are the lifeblood for those of us with CLL and the only way that our treatment has improved. But clinical trial design is existentially flawed, leading to poor accrual
Clinicaltrials.gov is a US-based website that requires companies and investigators to post information about clinical trials in a public forum. All US trials should be posted within about 3 weeks of
The FDA is revising clinical trials to improve safety, and CLL Society’s Dr. Brian Koffman was asked to serve as the patient representative
One click to our most popular content.
